Identification of the signals for glucose-induced insulin secretion in INS1 (832/13) -cells using metformin-induced metabolic deceleration as a model
| dc.contributor.author | Lamontagne, Julien | |
| dc.contributor.author | Al-Mass, Anfal | |
| dc.contributor.author | Nolan, Christopher | |
| dc.contributor.author | Corkey, Barbara E | |
| dc.contributor.author | Murthy Madiraju, S.R | |
| dc.contributor.author | Joly, Erik | |
| dc.contributor.author | Prentki, Marc | |
| dc.date.accessioned | 2022-06-16T23:52:48Z | |
| dc.date.available | 2022-06-16T23:52:48Z | |
| dc.date.issued | 2017 | |
| dc.date.updated | 2022-06-26T08:17:25Z | |
| dc.description.abstract | Metabolic deceleration in pancreatic -cells is associated with inhibition of glucose-induced insulin secretion (GIIS), but only in the presence of intermediate/submaximal glucose concentrations. Here, we used acute metformin treatment as a tool to induce metabolic deceleration in INS1 (832/13) -cells, with the goal of identifying key pathways and metabolites involved in GIIS. Metabolites and pathways previously implicated as signals for GIIS were measured in the cells at 2-25 mm glucose, with or without 5 mm metformin. We defined three criteria to identify candidate signals: 1) glucose-responsiveness, 2) sensitivity to metformin-induced inhibition of the glucose effect at intermediate glucose concentrations, and 3) alleviation of metformin inhibition by elevated glucose concentrations. Despite the lack of recovery from metformin-induced impairment of mitochondrial energy metabolism (glucose oxidation, O-2 consumption, and ATP production), insulin secretion was almost completely restored at elevated glucose concentrations. Meeting the criteria for candidates involved in promoting GIIS were the following metabolic indicators and metabolites: cytosolic NAD(+)/NADH ratio (inferred from the dihydroxyacetone phosphate:glycerol-3-phosphate ratio), mitochondrial membrane potential, ADP, Ca2+, 1-monoacylglycerol, diacylglycerol, malonyl-CoA, and HMG-CoA. On the contrary, most of the purine and nicotinamide nucleotides, acetoacetyl-CoA, H2O2, reduced glutathione, and 2-monoacylglycerol were not glucose-responsive. Overall these results underscore the significance of mitochondrial energy metabolism-independent signals in GIIS regulation; in particular, the candidate lipid signaling molecules 1-monoacylglycerol, diacylglycerol, and malonyl-CoA; the predominance of K-ATP/Ca2+ signaling control by low ADPMg(2+) rather than by high ATP levels; and a role for a more oxidized state (NAD(+)/NADH) in the cytosol during GIIS that favors high glycolysis rates. | |
| dc.description.sponsorship | This study was supported by grants from Canadian Institutes of Health Research (to MP and SRMM) and a scholarship from Kuwait University to AA. MP holds the Canada Research Chair in Diabetes and Metabolism | en_AU |
| dc.format.mimetype | application/pdf | en_AU |
| dc.identifier.issn | 0021-9258 | en_AU |
| dc.identifier.uri | http://hdl.handle.net/1885/267344 | |
| dc.language.iso | en_AU | en_AU |
| dc.provenance | This is an open access article under the CC BY license | en_AU |
| dc.publisher | American Society for Biochemistry and Molecular Biology Inc | |
| dc.rights | Copyright 2017 by The American Society for Biochemistry and Molecular Biology, Inc. | |
| dc.rights.license | Creative Commons Attribution License | en_AU |
| dc.rights.uri | https://creativecommons.org/licenses/by/4.0/ | en_AU |
| dc.source | Journal of Biological Chemistry | |
| dc.source.uri | http://dx.doi.org/10.1074/jbc.M117.808105 | |
| dc.subject | beta cell | |
| dc.subject | glucose metabolism | |
| dc.subject | insulin secretion | |
| dc.subject | metformin | |
| dc.subject | metabolic coupling factors | |
| dc.subject | metabolic deceleration | |
| dc.subject | mitochondrial metabolism | |
| dc.title | Identification of the signals for glucose-induced insulin secretion in INS1 (832/13) -cells using metformin-induced metabolic deceleration as a model | |
| dc.type | Journal article | |
| dcterms.accessRights | Open Access | en_AU |
| local.bibliographicCitation.issue | 47 | en_AU |
| local.bibliographicCitation.lastpage | 19468 | en_AU |
| local.bibliographicCitation.startpage | 19458 | en_AU |
| local.contributor.affiliation | Lamontagne, Julien, Universite de Montreal | en_AU |
| local.contributor.affiliation | Al-Mass, Anfal, McGill University | en_AU |
| local.contributor.affiliation | Nolan, Christopher, College of Health and Medicine, ANU | en_AU |
| local.contributor.affiliation | Corkey, Barbara E, Boston University | en_AU |
| local.contributor.affiliation | Murthy Madiraju, S.R, CRCHUM - Montreal University Hospital Research Centre | en_AU |
| local.contributor.affiliation | Joly, Erik, University of Montreal | en_AU |
| local.contributor.affiliation | Prentki, Marc, University of Montreal | en_AU |
| local.contributor.authoruid | Nolan, Christopher, u1820721 | en_AU |
| local.description.notes | Imported from ARIES | en_AU |
| local.identifier.absfor | 110306 - Endocrinology | en_AU |
| local.identifier.absfor | 110107 - Metabolic Medicine | en_AU |
| local.identifier.absfor | 111601 - Cell Physiology | en_AU |
| local.identifier.absseo | 920104 - Diabetes | en_AU |
| local.identifier.ariespublication | u5369653xPUB177 | en_AU |
| local.identifier.citationvolume | 292 | en_AU |
| local.identifier.doi | 10.1074/jbc.M117.808105 | en_AU |
| local.publisher.url | https://www.jbc.org/ | en_AU |
| local.type.status | Published Version | en_AU |
Downloads
Original bundle
1 - 1 of 1
Loading...
- Name:
- PIIS0021925820329124.pdf
- Size:
- 2.03 MB
- Format:
- Adobe Portable Document Format
- Description: